Plastic Surgery
What Is Mia FemTech? Smart Breast Implant Guide
A single incision in the axilla, local anaesthesia, and a natural 1–2 cup size increase — we compare the Mia FemTech system with conventional silicone implants side by side

On this page
What Is Mia FemTech? The Short Answer
Mia FemTech is a minimally invasive breast augmentation system performed through a small incision in the axilla, under local anaesthesia and sedation. It is developed by Swiss-Costa Rican company Establishment Labs. At its centre is the diamond-shaped, soft silicone gel Ergonomix2 Diamond implant, together with a dedicated power injection device that delivers the implant through the small incision.
Nis Clinic is the only certified centre performing Mia FemTech in Northern Cyprus (TRNC). The procedure is carried out by Op. Dr. İbrahim Meyzin, Specialist in Plastic, Reconstructive and Aesthetic Surgery (Cyprus Turkish Medical Association (CTMA), Registration No. 969), certified by Establishment Labs for this system.
This article is not a sales page. Its aim is to answer the question "what is Mia FemTech?" honestly: what the system is, how it differs from a conventional silicone implant, who it makes sense for, and how recovery unfolds. For technical process and pricing detail, the Mia FemTech service page is a separate resource.
How Does the System Work?
The easiest way to understand Mia FemTech is to see that it has two parts: an implant and a delivery device.
The implant — Ergonomix2 Diamond. A symmetrical, diamond-shaped implant made of soft, cohesive silicone gel. The clinical logic of the diamond form is this: even if the implant rotates at any angle, the upper and lower faces are identical, so no visible asymmetry results. Rotation — the best-known drawback of anatomical (teardrop) implants — is substantially reduced by this design. The outer shell is manufactured with a SmoothSilk® nanotextured surface; at 4-micron precision, this surface is associated in the clinical literature with lower bacterial adherence and lower capsular contracture rates.
The device — power injection. Conventional silicone implants are placed by hand through a 4–5 cm incision. With Mia FemTech, the implant is delivered through a much smaller incision using a specially designed injector device. The incision is in the axilla, not on the breast.
Where Is the Incision Made? (An Important Distinction)
With Mia FemTech, the incision is in the axilla (transaxillary approach) — not in the inframammary fold. The implant is placed into the supra-muscular intralaminar plane, between the breast tissue and the chest muscle.
Why these two points matter:
- No visible scar on the breast. The axillary scar measures around 5–10 mm and is largely concealed within the natural skin fold. Low-cut clothing and swimwear do not reveal a breast scar.
- Don't confuse the incision site. You may come across inaccurate information online suggesting Mia is performed "through the inframammary fold" or "through the areola." The correct information: the system is built around an axillary approach.
Mia FemTech Is Not an "Injection"
The term "injectable implant" is commonly used in marketing, and it is a term that invites misunderstanding. To be clear: Mia FemTech does not inject gel, fat or filler into the breast. What is placed is a pre-shaped, solid silicone implant. "Injectable" refers only to the fact that the implant is delivered through a small incision using a pressurised device — not that the implant itself is liquid.
This distinction has a practical consequence: Mia FemTech is a surgical procedure. Descriptions such as "non-surgical" or "needle breast augmentation" misrepresent the system.
How Does It Differ from a Conventional Silicone Implant?
Mia FemTech is not "better" than a conventional silicone implant — it serves a different purpose. For a patient targeting a large, pronounced volume increase (3+ cup sizes), a conventional silicone implant is more suitable. For a patient prioritising a natural look, a slim silhouette and rapid recovery, Mia FemTech offers an advantage.
Let's look at the differences by technical heading:
| Feature | Conventional Silicone Implant | Mia FemTech |
|---|---|---|
| Incision site | Inframammary fold or around the areola (4–5 cm) | Axilla (single small incision) |
| Placement plane | Submuscular or subglandular | Supra-muscular intralaminar |
| Anaesthesia | General anaesthesia | Local anaesthesia + sedation |
| Operating time | 1–2 hours | Typically 15–20 minutes |
| Volume range | Wide (1 to 4+ cup sizes) | Typically 1–2 cup sizes |
| Implant shape | Round or anatomical (teardrop) | Diamond (rotation-neutral) |
| Scar on the breast | May be visible | None (scar is in the axilla) |
| Return to light activity | 1–2 weeks | Hours to a few days |
| Return to full activity | 4–6 weeks | 2–4 weeks |
We are not presenting one column as "superior" to the other in this table. The conventional implant's wide volume range is a genuine advantage; Mia's short recovery is too. The right system depends on your goal and your anatomy. If you would like a detailed comparison of the two approaches across eight technical decisions, choosing a breast implant covers all of them.
Who Is a Candidate for Mia FemTech?
Mia FemTech is not the right system for every patient. At Nis Clinic we discuss this openly at the start of the consultation; telling an unsuitable patient the system is "suitable" prioritises the sale over the patient in the long run.
Good candidates:
- Those wanting a natural, not dramatic, increase of 1–2 cup sizes
- Those with thin tissue or an athletic build who face a risk of rippling with conventional implants
- Those who want a fast return to work and sport and cannot tolerate a long recovery
- Those who wish to avoid general anaesthesia, for personal or health reasons
- Those concerned about rotation with anatomical implants
- Those who do not want a visible scar on the breast
Cases that are not suitable, or where an alternative is considered:
- Those seeking a large volume increase of 3+ cup sizes — the Mia implant volume cannot reach this goal, so a conventional implant is recommended
- Those with pronounced nipple ptosis (grade 2–3) — a breast lift (mastopexy) may be needed first
- Those whose tissue cover is too thin to conceal the implant
- Pregnancy, breastfeeding, or active breast disease
In short: Mia FemTech is designed for a profile that wants "modest but natural" and prioritises fast recovery. If the goal is "a pronounced volume change," the system may not be the right tool for you.
Recovery Timeline: What to Expect
The defining difference with Mia FemTech is its speed of recovery. It is nonetheless a surgical procedure; it requires patience and compliant follow-up.
- First 24 hours: Mild tightness and sensitivity are normal. Simple analgesics are generally sufficient. Sleep on your back, head elevated.
- Days 2–3: Showering is permitted. Arm movements remain limited — avoid actions such as brushing your hair or reaching for items on high shelves.
- Days 5–7: Clinic review and suture check. The axillary scar is largely concealed within the skin fold by this point.
- Week 2: Return to desk-based work is possible for most patients. For physically demanding occupations, 3–4 weeks is recommended.
- Week 4: Light exercise such as walking and Pilates is generally permitted. Upper-body weight training requires your surgeon's approval.
- Months 3–6: Tissue settling is complete; the breast's final position and natural drape become clear.
For our international patients, follow-up after the day 5–7 review continues by photo via WhatsApp. In accordance with the manufacturer's protocol, contact with the surgical team is maintained throughout the first year; routine mammography and breast surveillance are scheduled at intervals consistent with standard guidelines.
Safety, Clinical Data and Risks
The most honest section on any breast augmentation system is the complications and risk section. No surgical procedure is risk-free.
Regulatory approval. The Ergonomix2 Diamond implant received European Union CE 2797 approval in December 2020 and is in use across markets including Europe, the United Kingdom, Japan, Switzerland, Sweden, Spain and Dubai. FDA approval is under review for the US market; the implant is not yet commercially available there. Because CE-approved medical device regulation applies in the TRNC, Mia FemTech is performed here lawfully and under licence.
Clinical data. The most current reference for the system is a prospective study following 100 patients over 3 years (PubMed 41052824). In this study, 75.3% of patients reported a 1–3 bra cup size increase; the 3-year Kaplan-Meier complication rate was measured at 3.2%. No rupture, Baker III/IV capsular contracture, infection, haematoma, seroma or BIA-ALCL case was recorded during the study period. The limits of this data are clear too: the sample is 100 patients, follow-up is 3 years, and longer-term data are still being collected. Individual results vary.
General surgical risks. As with any breast augmentation, risks include infection, bleeding, variation in scar healing, asymmetry, and risks associated with anaesthesia. Local anaesthesia reduces some risks compared with general anaesthesia, but it does not make the procedure "risk-free." A detailed risk assessment based on your personal health status is carried out at consultation; these points are explained one by one during the informed consent process.
The Process and Transparent Pricing at Nis Clinic
The process runs across four stages: an online initial assessment, in-clinic measurement and size trial, the day of surgery, and follow-up.
We conduct the first consultation by Zoom or WhatsApp video call, which is practical for most of our international patients. In the clinic, a sizer (trial implant) fitting is our standard protocol — you decide by trying sterile trial implants of different volumes inside a bra, on your own body. You see it on your own silhouette, not in an abstract simulation. Op. Dr. İbrahim Meyzin is personally present during surgery; we plan 1–3 cases a day, so the attention given to each patient is preserved.
Price. At Nis Clinic, the Mia FemTech package sits within an average range of €9,000–€12,000 (2026 reference). This figure is not a fixed marketing label; it is a structural cost arising from the premium implant, the single-use injection kit and Establishment Labs certification. A conventional silicone breast augmentation package costs less because it is a different system — this is not "cheaper/more expensive," it is a different purpose. The package includes airport transfer, 2–3 nights' accommodation, surgery, implant and injection kit, local anaesthesia, medication, a post-operative bra, first-year reviews and the MotivaImagine implant registration system. A confirmed figure is given after a complimentary consultation and examination.
To find out whether Mia FemTech is right for you, book a consultation or speak with our team via our medical tourism packages. Detailed technical process: Mia FemTech service page.
Frequently Asked Questions
Is Mia FemTech a non-surgical procedure?
Where is the Mia FemTech incision made?
How many cup sizes does Mia FemTech increase?
What is the main difference between Mia FemTech and a conventional silicone implant?
How soon can I return to work and exercise after Mia FemTech?
Is the Mia FemTech implant permanent, and when is it replaced?
Does Mia FemTech affect breastfeeding?
Is Mia FemTech CE and FDA approved?
Where is Mia FemTech performed in the TRNC?
How much does Mia FemTech cost?
Your personal roadmap
In a free 15-minute online consultation, Dr. Meyzin provides a clear, personalised assessment.